Patents by Inventor Mi Young Ko

Mi Young Ko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amide derivative for inhibiting the growth of cancer cells
    Patent number: 8188102
    Abstract: The present invention provides a novel amide derivative of formula (I) and a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same as an active ingredient.
    Type: Grant
    Filed: June 5, 2008
    Date of Patent: May 29, 2012
    Assignee: Hanmi Holdings Co., Ltd.
    Inventors: Kwang-Ok Lee, Mi Young Cha, Mi Ra Kim, Young Hee Jung, Chang Gon Lee, Se Young Kim, Keukchan Bang, Bum Woo Park, Bo Im Choi, Yun Jung Chae, Mi Young Ko, Han Kyong Kim, Young-Gil Ahn, Maeng Sup Kim, Gwan Sun Lee
  • Method preparation clopidogrel and intermediates used therein
    Patent number: 7763730
    Abstract: Optically pure clopidogrel can be prepared in a high yield by optically resolving a racemic form of the compound of formula (II) using an optically active amine to form the optically active form of the compound of formula (III) or its acid-addition salt; and methylating the compound of formula (III) or its acid-addition salt.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: July 27, 2010
    Assignee: Hanmi Pharm. Co., Ltd
    Inventors: Eun Sook Kim, Hee Cheol Kim, Bo Sung Kwon, Sangmin Yun, Mi Young Ko, Cheol Kyung Kim, Kwee Hyun Suh
  • NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS
    Publication number: 20100179120
    Abstract: The present invention provides a novel amide derivative and a pharmaceutically acceptable salt thereof which selectively and effectively inhibits the growth of cancer cells induced by the overexpression of an epidermal growth factor receptor and also prevents the development of drug resistance caused by the mutation of EGFR tyrosine kinase, and a pharmaceutical composition comprising same as an active ingredient.
    Type: Application
    Filed: June 5, 2008
    Publication date: July 15, 2010
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Kwang-Ok Lee, Mi Young Cha, Mi Ra Kim, Young Hee Jung, Chang Gon Lee, Se Young Kim, Keukchan Bang, Bum Woo Park, Bo Im Choi, Yun Jung Chae, Mi Young Ko, Han Kyong Kim, Young-Gil Ahn, Maeng Sup Kim, Gwan Sun Lee
  • Method of preparing clopidogrel and intermediates used therein
    Patent number: 7652140
    Abstract: Optically pure clopidogrel can be prepared in a high yield by optically resolving a racemic form of the compound of formula (II) using an optically active amine to form the optically active form of the compound of formula (III) or its acid-addition salt; and methylating the compound of formula (III) or its acid-addition salt.
    Type: Grant
    Filed: November 28, 2005
    Date of Patent: January 26, 2010
    Assignee: Hanmi Pharm. Co., Ltd
    Inventors: Eun Sook Kim, Hee Cheol Kim, Bo Sung Kwon, Sangmin Yun, Mi Young Ko, Cheol Kyung Kim, Kwee Hyun Suh
  • METHOD PREPARATION CLOPIDOGREL AND INTERMEDIATES USED THEREIN
    Publication number: 20090318701
    Abstract: Optically pure clopidogrel can be prepared in a high yield by optically resolving a racemic form of the compound of formula (II) using an optically active amine to form the optically active form of the compound of formula (III) or its acid-addition salt; and methylating the compound of formula (III) or its acid-addition salt.
    Type: Application
    Filed: August 28, 2009
    Publication date: December 24, 2009
    Applicant: HANMI PHARM CO., LTD.
    Inventors: Eun Sook KIM, Hee Cheol KIM, Bo Sung KWON, Sangmin YUN, Mi Young KO, Cheol Kyung KIM, Kwee Hyun SUH
  • Method of Preparing Clopidogrel and Intermediates Used Therein
    Publication number: 20080214821
    Abstract: Optically pure clopidogrel can be prepared in a high yield by optically resolving a racemic form of the compound of formula (II) using an optically active amine to form the optically active form of the compound of formula (III) or its acid-addition salt; and methylating the compound of formula (III) or its acid-addition salt.
    Type: Application
    Filed: November 28, 2005
    Publication date: September 4, 2008
    Applicant: Hanmi Pharm., Co., Ltd.
    Inventors: Eun Sook Kim, Hee Cheol, Bo Sung Kwon, Sangmin Yun, Mi Young Ko, Cheol Kyung Kim, Kwee Hyun Suh